Stay updated on ADVANCE-2 Pimavanserin Clinical Trial
Sign up to get notified when there's something new on the ADVANCE-2 Pimavanserin Clinical Trial page.

Latest updates to the ADVANCE-2 Pimavanserin Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice about government funding affecting data updates was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check8 days agoChange DetectedUI updates include a glossary toggle and color-coded highlights (green for additions, red for deletions) in the record history. The revision label was updated to v3.4.0 (removing v3.3.4) and there is a capitalization change for 'No FEAR Act Data'.SummaryDifference0.8%

- Check15 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check65 days agoChange DetectedA new history version, v3.3.2, was added and the previous version, v3.3.1, removed from the list. This reflects a routine update to the record history display on the page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe record history shows a new revision (v3.3.1) replacing the previous revision (v3.2.0). This appears to be a metadata update rather than a substantive change to study information.SummaryDifference0.1%

Stay in the know with updates to ADVANCE-2 Pimavanserin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVANCE-2 Pimavanserin Clinical Trial page.